Managing nonmalignant chronic abdominal pain and malignant bowel obstruction

Gastroenterology Clinics of North America
Lesley K BicanovskyDeclan Walsh

Abstract

Evaluation of abdominal pain requires an understanding of the possible causes(benign or malignant) and recognition of typical patterns and clinical presentation. Abdominal pain has multiple causes; associated signs and symptoms may aid in the diagnosis. Remember that some patients will not have a textbook presentation, and unusual causes for pain must be considered. Those with chronic pancreatitis with structural complications should be operated on early, whereas those with other types of chronic pancreatitis should receive medical therapy focusing on alleviating symptoms. Control of the most troublesome symptoms will provide the best management for IBS. Pharmacologic success in bowel obstruction depends on the level and degree of obstruction. Decision making is based on reasonable expectations of survival, treatment-related success, performance status, and goals of care. Quality of life will be enhanced by appropriate symptom management.

References

Nov 1, 1992·Journal of Pain and Symptom Management·S Mercadante, S Maddaloni
Jan 1, 1992·Psychosomatics·S J Eisendrath, K T Kodama
Jun 15, 1992·Annals of Internal Medicine·D A Drossman, W G Thompson
Jan 11, 1992·BMJ : British Medical Journal·R Jones, S Lydeard
Jan 1, 1988·Baillière's Clinical Gastroenterology·F Cervero
Aug 1, 1987·American Journal of Clinical Oncology·A R Kagan, J D Kagan
Nov 1, 1984·Archives of Surgery·J T DunnT V Berne
Jun 1, 1983·Pflügers Archiv : European journal of physiology·P HauptW Kohler
Apr 1, 1995·Palliative Medicine·B M MountD J Dudgeon
Jun 1, 1995·The New England Journal of Medicine·M L SteerS Freedman
Jul 1, 1994·Journal of Pain and Symptom Management·R L FainsingerJ Hanson
Dec 23, 1993·The New England Journal of Medicine·R B Lynn, L S Friedman
Feb 1, 1994·AJR. American Journal of Roentgenology·E J Balthazar
Sep 1, 1993·AJR. American Journal of Roentgenology·M J LeeA M Cats
Jan 1, 1996·Anti-cancer Drugs·H S Pandha, J Waxman
Nov 20, 1997·Lancet·K Mergener, J Baillie
Nov 20, 1998·JAMA : the Journal of the American Medical Association·D M EisenbergR C Kessler
Jul 15, 1999·JAMA : the Journal of the American Medical Association·D MelchartR Bauer
Mar 4, 2000·European Journal of Pain : EJP·M A Giamberardino
Mar 7, 2000·The British Journal of Radiology·D M CollR C Smith
May 2, 2000·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·S MercadanteL Groff
Sep 15, 2000·BMJ : British Medical Journal·A Vickers
Oct 13, 2000·Lancet·F Cervero
Nov 15, 2000·Gut·F Cervero
Dec 15, 2000·Archives of Family Medicine·A BensoussanA L Carlton
Dec 21, 2000·Current Oncology Reports·M P Davis, C Nouneh
Jan 10, 2002·American Journal of Therapeutics·Kenneth S LattaRobert L Barkin
Aug 20, 2002·Journal of Clinical Gastroenterology·Michael J Callahan
Sep 28, 2002·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Tatsuya MoritaSatoshi Chihara
Mar 13, 2003·Emergency Medicine Clinics of North America·Richard A KaminRobert D Powers
Mar 13, 2003·Current Gastroenterology Reports·Virmeet V Singh, Phillip P Toskes
Mar 22, 2003·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Julie C SheaSteven D Freedman
Mar 27, 2003·Journal of Hepato-biliary-pancreatic Surgery·John P Duffy, Howard A Reber
Mar 27, 2003·Journal of Hepato-biliary-pancreatic Surgery·Charles P MorrisonGuy J Maddern
May 17, 2003·News in Physiological Sciences : an International Journal of Physiology Produced Jointly by the International Union of Physiological Sciences and the American Physiological Society·Anthony R Hobson, Qasim Aziz

❮ Previous
Next ❯

Citations

Nov 10, 2012·The Journal of Supportive Oncology·Mona GuptaRuth Lagman
Feb 1, 2007·Expert Review of Pharmacoeconomics & Outcomes Research·Geoffrey P Dunn
Jun 26, 2018·Frontiers in Integrative Neuroscience·Xuan-Zheng ShiShrilakshmi Hegde

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.